Compare Arita Prima Indonesia Tbk (APII) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arita Prima Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Arita Prima Indonesia Tbk trades at Rp190 (market cap 201.17B, 978.8K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp238 (market cap 164.65B, 50.3K 24h volume). The key difference: Arita Prima Indonesia Tbk is the larger of the two by market cap, and Arita Prima Indonesia Tbk is more actively traded (978.8K versus 50.3K). Which is the better fit depends on your goals.
| APII | OBAT | |
|---|---|---|
Market Cap | 201.17B | 164.65B |
Volume | 978.8K | 50.3K |
Lot | 9.79K | 503 |
Turnover | 184.83M | 12.13M |
Average Price | 188.84 | 241.18 |
Value | 184.83M | 12.13M |
Indicative Equilibrium Price | — | 238 |
Indicative Equilibrium Volume | — | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Arita Prima Indonesia Tbk
PT Arita Prima Indonesia Tbk (the Company) was established on October 5, 2000. Since its founding in 2000, the company initially marketed under the brand Arita valve products manufactured by Unimech Group, a multinational business group from Malaysia that specializes in construction services and valve manufacturers, as well as supporting products. The Company is the only company that was granted by the relevant manufacturers in the distribution and marketing in Indonesia, for valve products from leading manufacturers in the world with brands Arita from Malaysia, RK Marine from China, and KVC from Japan.
Read more on APII →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
